Zobrazeno 1 - 10
of 22
pro vyhledávání: '"K. Katsirntaki"'
Autor:
K. Katsirntaki, S. Hagner, C. Werlein, P. Braubach, D. Jonigk, D. Adam, H. Hidaji, C. Kühn, C. S. Falk, A. Ruhparwar, B. Wiegmann
Publikováno v:
Transplant International, Vol 37 (2024)
Ex situ lung perfusion (ESLP) is used for organ reconditioning, repair, and re-evaluation prior to transplantation. Since valid preclinical animal models are required for translationally relevant studies, we developed a 17 mL low-volume ESLP for doub
Externí odkaz:
https://doaj.org/article/af19b967b80f420ca297e7b06466555e
Autor:
Jana Keil, J. Kühne, Susanne Iordanidis, Johanna Egelkamp, Cornelia Blume, Jan Hinrich Bräsen, K. Katsirntaki, R. Bellmas-Sanz, Kerstin Daemen, Evgeny Chichelnitskiy, Kevin Hake, Christine S. Falk, F Wandrer, Jessica Schmitz, Hermann Haller, C. Neudörfl, A. Akhdar
Publikováno v:
American Journal of Transplantation. 19:2692-2704
The role of endothelial cells in the pathophysiology of antibody-mediated rejection after renal transplantation has been widely investigated. We expand this scenario to the impact of epithelial cells on the microenvironment during rejection. Primary
Autor:
S. Jurmann, M. Mälzer, Michael Pflaum, Axel Haverich, C. Hartl, Z. Vukadinovic-Nikolic, Bettina Wiegmann, K. Katsirntaki
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S53-S54
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S300
Purpose Left ventricular assist devices (LVADs) are established implantable devices in patients with end-stage heart failure. Due to their artificial materials, anticoagulative therapy is needed, though leading to partly lethal complications and limi
Autor:
K. Katsirntaki, Axel Haverich, S. Jurmann, Ruth Olmer, Bettina Wiegmann, R. Blasczyck, Ulrich Martin, Michael Pflaum, Constanca Figueiredo
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S177-S178
Purpose Lung transplantation is the only curative therapy option for patients suffering from end stage lung diseases. However, it is associated with high risks and only available for selected patients. In order to provide an alternative treatment opt
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S356
Purpose Lung transplantation remains the only treatment option for patients with end-stage lung disease. Although surgical techniques and organ preservation significantly improved over the last decades, ischemia and reperfusion injuries, which inter
Autor:
Tobias Cantz, Marcus A. Mall, Malte Sgodda, Sabrina Schmeckebier, T Braus, Julia Duerr, Christina Mauritz, Verena Puppe, K. Katsirntaki, SC Schuber, Ulrich Martin, Isabelle Salwig, Andreas Schmiedl, Marten Szibor, Reto Eggenschwiler, Matthias Ochs
Publikováno v:
Pneumologie. 68
Publikováno v:
Journal of stem cellsregenerative medicine. 6(2)
Autor:
A. Bader, A. Brodarac, R. Hetzer, A. Kurtz, C. Stamm, H. Baraki, G. Kensah, S. Asch, S. Rojas, A. Martens, I. Gruh, A. Haverich, I. Kutschka, L. Cortes-Dericks, L. Froment, G. Kocher, R. A. Schmid, E. Delyagina, A. Schade, D. Scharfenberg, A. Skorska, C. Lux, W. Li, G. Steinhoff, F. Drey, V. Lepperhof, K. Neef, A. Fatima, T. Wittwer, T. Wahlers, T. Saric, Y.- H. Choi, D. Fehrenbach, A. Lehner, F. Herrmann, T. Hollweck, S. Pfeifer, E. Wintermantel, R. Kozlik-Feldmann, C. Hagl, B. Akra, M. Gyongyosi, M. Zimmermann, N. Pavo, M. Mildner, M. Lichtenauer, G. Maurer, J. Ankersmit, S. Hacker, R. Mittermayr, T. Haider, S. Nickl, L. Beer, D. Lebherz-Eichinger, T. Schweiger, A. Mitterbauer, C. Keibl, G. Werba, M. Frey, H. J. Ankersmit, S. Herrmann, C. A. Lux, J. Holfeld, C. Tepekoylu, F.- S. Wang, R. Kozaryn, W. Schaden, M. Grimm, C.- J. Wang, A. Urbschat, K. Zacharowski, P. Paulus, M. J. Avaca, H. Kempf, D. Malan, P. Sasse, B. Fleischmann, J. Palecek, G. Drager, A. Kirschning, R. Zweigerdt, U. Martin, K. Katsirntaki, R. Haller, S. Ulrich, M. Sgodda, V. Puppe, J. Duerr, A. Schmiedl, M. Ochs, T. Cantz, M. Mall, C. Mauritz, A. R. Lara, J. Dahlmann, K. Schwanke, J. Hegermann, D. Skvorc, A. Gawol, A. Azizian, S. Wagner, A. Krause, C. Klopsch, R. Gaebel, A. Kaminski, B. Chichkov, S. Jockenhoevel, K. Klose, R. Roy, K.- S. Kang, K. Bieback, B. Nasseri, O. Polchynska, K. Kruttwig, C. Bruggemann, G. Xu, A. Baumgartner, M. Hasun, B. K. Podesser, M. Ludwig, A. Tolk, T. Noack, R. Margaryan, N. Assanta, A. Menciassi, S. Burchielli, M. Matteucci, V. Lionetti, C. Luchi, E. Cariati, F. Coceani, B. Murzi, S. V. Rojas, A. Rotarmel, B. A. Nasseri, W. Ebell, M. Dandel, M. Kukucka, R. Gebker, H. Mutlak, P. Ockelmann, S. Tacke, B. Scheller, A. Pereszlenyi, M. Meier, N. Schecker, C. Rathert, P. M. Becher, N. Drori-Carmi, N. Bercovich, E. Zahavi-Goldstein, M. Jack, N. Netzer, L. Pinzur, A. Chajut, C. Tschope, U. Ruch, B.- E. Strauer, G. Tiedemann, F. Schlegel, S. Dhein, O. Akhavuz, F. W. Mohr, P. M. Dohmen, A. Salameh, K. Oelmann, P. Kiefer, S. Merkert, C. Templin, M. Jara-Avaca, S. Muller, S. von Haehling, S. Slavic, C. Curato, W. Altarche-Xifro, T. Unger, J. Li, Y. Zhang, W. Z. Li, L. Ou, N. Ma, A. Haase, R. Alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::581afc54d020e6355b81aaae93c0d7b2
https://europepmc.org/articles/PMC3548555/
https://europepmc.org/articles/PMC3548555/
Autor:
K. Katsirntaki, Susanne C. Schubert, Gerald Draeger, Malte Sgodda, Verena Puppe, Matthias Ochs, Andreas Schmiedl, Qiong Lin, Martin Zenke, Sabrina Schmeckebier, Christina Mauritz, Ulrich Martin, Jiri Paleček, Julia Duerr, Marcus A. Mall, Tobias Cantz
Publikováno v:
Tissue engineering. Part A. 19(7-8)
Alveolar epithelial type II (ATII)-like cells can be generated from murine embryonic stem cells (ESCs), although to date, no robust protocols applying specific differentiation factors are established. We hypothesized that the keratinocyte growth fact